KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Inventory (2016 - 2025)

NovoCure's Inventory history spans 12 years, with the latest figure at $41.1 million for Q4 2025.

  • For Q4 2025, Inventory rose 17.17% year-over-year to $41.1 million; the TTM value through Dec 2025 reached $41.1 million, up 17.17%, while the annual FY2025 figure was $41.1 million, 17.17% up from the prior year.
  • Inventory for Q4 2025 was $41.1 million at NovoCure, up from $39.1 million in the prior quarter.
  • Across five years, Inventory topped out at $42.4 million in Q1 2024 and bottomed at $22.6 million in Q3 2021.
  • The 5-year median for Inventory is $34.1 million (2023), against an average of $33.7 million.
  • The largest annual shift saw Inventory dropped 14.49% in 2021 before it skyrocketed 37.38% in 2023.
  • A 5-year view of Inventory shows it stood at $24.4 million in 2021, then increased by 20.26% to $29.4 million in 2022, then increased by 29.87% to $38.2 million in 2023, then decreased by 8.04% to $35.1 million in 2024, then increased by 17.17% to $41.1 million in 2025.
  • Per Business Quant, the three most recent readings for NVCR's Inventory are $41.1 million (Q4 2025), $39.1 million (Q3 2025), and $40.2 million (Q2 2025).